Thomas W. Elrod

• Name Huntington Ingalls Industries, Inc.
• Type Securities
• Status Investigating
• The law firm of Kirby McInerney LLP announces that it is investigating potential claims against Huntington Ingalls Industries, Inc. (“Huntington Ingalls” or the “Company”) (NYSE: HII). The investigation concerns whether Huntington Ingalls and/or certain of its officers have violated the federal securities laws and/or engaged in other unlawful business practices.
   

• Name Marqeta, Inc.
• Type Securities
• Status Investigating
• The law firm of Kirby McInerney LLP is investigating potential claims against Marqeta, Inc. (“Marqeta” or the “Company”) (NASDAQ: MQ). The investigation concerns whether Marqeta and/or certain of its officers have violated the federal securities laws and/or engaged in other unlawful business practices.

• Name MediaAlpha, Inc.
• Type Securities
• Status Investigating
• The law firm of Kirby McInerney LLP is investigating potential claims against MediaAlpha, Inc. (“MediaAlpha” or the “Company”) (NYSE: MAX) The investigation concerns whether MediaAlpha and/or certain of its officers have violated the federal securities laws and/or engaged in other unlawful business practices.

• Name Xerox Holdings Corporation
• Type Securities
• Status Investigating
• The law firm of Kirby McInerney LLP is investigating potential claims against Xerox Holdings Corporation (“Xerox” or the “Company”) (NASDAQ: XRX). The investigation concerns whether Xerox and/or certain of its officers have violated the federal securities laws and/or engaged in other unlawful business practices.

• Name Flux Power Holdings, Inc.
• Type Securities
• Status Investigating
• The law firm of Kirby McInerney LLP announces that a class action lawsuit has been filed in the U.S. District Court for the District of Nevada on behalf of those who acquired Flux Power Holdings, Inc. (“Flux Power” or the “Company”) (NASDAQ: FLUX) securities during the period of November 11, 2022 to September 30, 2024, inclusive (“the Class Period”). Investors have until December 31, 2024, to apply to the Court to be appointed as lead plaintiff in the lawsuit.
   

• Name PACS Group, Inc.
• Type Securities
• Status Investigating
• The law firm of Kirby McInerney LLP is investigating potential claims against PACS Group, Inc. (“PACS” or the “Company”) (NYSE: PACS). The investigation concerns whether PACS and/or certain of its officers have violated the federal securities laws and/or engaged in other unlawful business practices.
   

• Name Evolv Technologies Holdings, Inc.
• Type Securities
• Status Investigating
• The law firm of Kirby McInerney LLP announces that a class action lawsuit has been filed in the U.S. District Court for the District of Massachusetts on behalf of those who acquired Evolv Technologies Holdings, Inc. (“Evolv” or the “Company”) (NASDAQ: EVLV) securities during the period of August 19, 2022 to October 30, 2024, inclusive (“the Class Period”). Investors have until December 31, 2024, to apply to the Court to be appointed as lead plaintiff in the lawsuit.

• Name DMC Global Inc.
• Type Securities
• Status Investigating
• The law firm of Kirby McInerney LLP is investigating potential claims against DMC Global Inc. (“DMC Global” or the “Company”) (NASDAQ: BOOM). The investigation concerns whether DMC Global and/or certain of its officers have violated the federal securities laws and/or engaged in other unlawful business practices.
   

• Name Humacyte, Inc.
• Type Securities
• Status Investigating
• The law firm of Kirby McInerney LLP is investigating potential claims against Humacyte, Inc. (“Humacyte” or the “Company”) (NASDAQ: HUMA). The investigation concerns whether Humacyte and/or certain of its officers have violated the federal securities laws and/or engaged in other unlawful business practices.
   

• Name Stride, Inc.
• Type Securities
• Status Investigating
• The law firm of Kirby McInerney LLP is investigating potential claims against Stride, Inc. (“Stride” or the “Company”) (NYSE: LRN). The investigation concerns whether Stride and/or certain of its officers have violated the federal securities laws and/or engaged in other unlawful business practices.
   

• Name CSX Corporation
• Type Securities
• Status Investigating
• The law firm of Kirby McInerney LLP is investigating potential claims against CSX Corporation (“CSX” or the “Company”) (NASDAQ: CSX). The investigation concerns whether CSX and/or certain of its officers have violated the federal securities laws and/or engaged in other unlawful business practices.
   

• Name MGP Ingredients, Inc.
• Type Securities
• Status Investigating
• The law firm of Kirby McInerney LLP is investigating potential claims against MGP Ingredients, Inc. (“MGP” or the “Company”) (NASDAQ: MGPI). The investigation concerns whether MGP and/or certain of its officers have violated the federal securities laws and/or engaged in other unlawful business practices.
   

• Name Acadia Healthcare Company, Inc.
• Type Securities
• Status Investigating
• The law firm of Kirby McInerney LLP announces that a class action lawsuit has been filed in the U.S. District Court for the Middle District of Tennessee on behalf of those who acquired Acadia Healthcare Company, Inc. (“Acadia” or the “Company”) (NASDAQ: ACHC) securities during the period of February 28, 2020 to September 26, 2024, inclusive (“the Class Period”). Investors have until December 16, 2024 to apply to the Court to be appointed as lead plaintiff in the lawsuit.
   

• Name Edwards Lifesciences Corporation
• Type Securities
• Status Investigating
• The law firm of Kirby McInerney LLP announces that a class action lawsuit has been filed in the U.S. District Court for the Central District of California on behalf of those who acquired Edwards Lifesciences Corporation (“Edwards Lifesciences” or the “Company”) (NYSE: EW) securities during the period of February 6, 2024 to July 24, 2024, inclusive (“the Class Period”). Investors have until December 13, 2024 to apply to the Court to be appointed as lead plaintiff in the lawsuit.

• Name Xiao-I Corporation
• Type Securities
• Status Investigating
• The law firm of Kirby McInerney LLP announces that a class action lawsuit has been filed in the U.S. District Court for the Southern District of New York on behalf of those who acquired Xiao-I Corporation (“Xiao-I” or the “Company”) (NASDAQ: AIXI) (a) American depository shares (“ADSs”) issued in connection with the Company’s initial public offering conducted on or about March 9, 2023 (the “IPO” or “Offering”); and/or (b) securities between March 9, 2023 and July 12, 2024, inclusive (the “Class Period”). Investors have until December 16, 2024, to apply to the Court to be appointed as lead plaintiff in the lawsuit.
   

• Name ADMA Biologics, Inc.
• Type Securities
• Status Investigating
• The law firm of Kirby McInerney LLP is investigating potential claims against ADMA Biologics, Inc. (“ADMA Biologics” or the “Company”) (NASDAQ: ADMA). The investigation concerns whether ADMA and/or certain of its officers have violated the federal securities laws and/or engaged in other unlawful business practices.
   

• Name Elanco Animal Health Incorporated
• Type Securities
• Status Investigating
• The law firm of Kirby McInerney LLP announces that a class action lawsuit has been filed in the U.S. District Court for the District of Maryland on behalf of those who acquired Elanco Animal Health Incorporated (“Elanco” or the “Company”) (NYSE: ELAN) securities during the period of November 7, 2024 to June 26, 2024, inclusive (“the Class Period”). Investors have until December 6, 2024 to apply to the Court to be appointed as lead plaintiff in the lawsuit.
   

• Name iLearningEngines, Inc.
• Type Securities
• Status Investigating
• The law firm of Kirby McInerney LLP announces that a class action lawsuit has been filed in the U.S. District Court for the District of Maryland on behalf of those who acquired iLearningEngines, Inc. (“iLearningEngines” or the “Company”) (NASDAQ: AILE) securities during the period of April 22, 2024 through August 28, 2024, inclusive (“the Class Period”). Investors have until December 6, 2024 to apply to the Court to be appointed as lead plaintiff in the lawsuit.

• Name Iris Energy Limited
• Type Securities
• Status Investigating
• The law firm of Kirby McInerney LLP announces that a class action lawsuit has been filed in the U.S. District Court for the Eastern District of New York on behalf of those who acquired Iris Energy Limited (“Iris” or the “Company”) (NASDAQ: IREN) securities during the period of June 20, 2023 through July 11, 2024, inclusive (“the Class Period”). Investors have until November 6, 2024 to apply to the Court to be appointed as lead plaintiff in the lawsuit.

• Name Renewable Innovations, Inc.
• Type Securities
• Status Investigating
• The law firm of Kirby McInerney LLP announces that a class action lawsuit has been filed in the U.S. District Court for the District of Utah on behalf of those who acquired Renewable Innovations, Inc. ("Renewable Innovations" or the "Company") (OTC BB: REII) securities during the period of December 1, 2022 through September 14, 2023 inclusive (the "Class Period"). Investors have until November 26, 2024 to apply to the Court to be appointed as lead plaintiff in the lawsuit.

• Name SIGA Technologies, Inc.
• Type Securities
• Status Investigating
• The law firm of Kirby McInerney LLP is investigating potential claims against SIGA Technologies, Inc. (“SIGA” or the “Company”) (NASDAQ: SIGA). The investigation concerns whether SIGA and/or certain of its officers have violated the federal securities laws and/or engaged in other unlawful business practices.
   

• Name Sunlight Financial Holdings, Inc. f/k/a Spartan Acquisition Corp. II et al.
• Type Securities
• Status Investigating
• The law firm of Kirby McInerney LLP announces that a class action lawsuit has been filed in the U.S. District Court for the Western District of Texas on behalf of those who acquired Sunlight Financial Holdings, Inc., formerly known as Spartan Acquisition Corp. II  (“Sunlight” or the “Company”) (Other: SUNLQ) securities during the period of January 25, 2021 through October 31, 2023, inclusive (“the Class Period”). Investors have until December 2, 2024 to apply to the Court to be appointed as lead plaintiff in the lawsuit.

• Name AMMO Incorporated
• Type Securities
• Status Investigating
• The law firm of Kirby McInerney LLP announces that a class action lawsuit has been filed in the U.S. District Court for the District of Arizona on behalf of those who acquired AMMO Incorporated (“Ammo” or the “Company”) (NASDAQ: POWW) securities during the period of August 19, 2020 to September 24, 2024, inclusive (“the Class Period”). Investors have until November 29, 2024 to apply to the Court to be appointed as lead plaintiff in the lawsuit.
   

• Name Paragon 28, Inc.
• Type Securities
• Status Investigating
• The law firm of Kirby McInerney LLP announces that a class action lawsuit has been filed in the U.S. District Court for the District of Colorado on behalf of those who acquired Paragon 28, Inc. (“Paragon 28” or the “Company”) (NYSE: FNA) securities during the period of May 5, 2023 through August 8, 2024, inclusive (“the Class Period”). Investors have until November 29, 2024 to apply to the Court to be appointed as lead plaintiff in the lawsuit.
   

• Name Terran Orbital Corporation
• Type Securities
• Status Investigating
• The law firm of Kirby McInerney LLP announces that a class action lawsuit has been filed in the U.S. District Court for the Southern District of Florida on behalf of those who acquired Terran Orbital Corporation (“Terran” or the “Company”) (NYSE: LLAP) securities during the period of August 15, 2023 through August 14, 2024, inclusive (“the Class Period”). Investors have until November 26, 2024 to apply to the Court to be appointed as lead plaintiff in the lawsuit.
   

• Name Metagenomi, Inc.
• Type Securities
• Status Investigating
• The law firm of Kirby McInerney LLP announces that a class action lawsuit has been filed in the U.S. District Court for the Northern District of California on behalf of those who acquired Metagenomi, Inc. (“Metagenomi” or the “Company”) (NASDAQ: MGX) securities during the period from February 9, 2024 through May 1, 2024, inclusive (“the Class Period”). Investors have until November 25, 2024 to apply to the Court to be appointed as lead plaintiff in the lawsuit.
   

• Name Revance Therapeutics, Inc.
• Type Securities
• Status Investigating
• The law firm of Kirby McInerney LLP is investigating potential claims against Revance Therapeutics, Inc. (“Revance” or the “Company”) (NASDAQ: RVNC). The investigation concerns whether Revance and/or certain of its officers have violated the federal securities laws and/or engaged in other unlawful business practices.

• Name Bumble Inc.
• Type Securities
• Status Investigating
• The law firm of Kirby McInerney LLP announces that a class action lawsuit has been filed in the U.S. District Court for the Western District of Texas on behalf of those who acquired Bumble Inc. (“Bumble” or the “Company”) (NASDAQ: BMBL) securities during the period of November 7, 2023 through August 7, 2024, inclusive (“the Class Period”). Investors have until November 25, 2024 to apply to the Court to be appointed as lead plaintiff in the lawsuit.
   

• Name Domino’s Pizza, Inc.
• Type Securities
• Status Investigating
• The law firm of Kirby McInerney LLP announces that a class action lawsuit has been filed in the U.S. District Court for the Eastern District of Michigan on behalf of those who acquired Domino’s Pizza, Inc. (“Domino’s” or the “Company”) (NYSE: DPZ) securities during the period of December 7, 2023 to July 17, 2024, inclusive (“the Class Period”). Investors have until November 19, 2024 to apply to the Court to be appointed as lead plaintiff in the lawsuit.
   

• Name New Fortress Energy Inc.
• Type Securities
• Status Investigating
• The law firm of Kirby McInerney LLP announces that a class action lawsuit has been filed in the U.S. District Court for the Southern District of New York on behalf of those who acquired New Fortress Energy Inc. (“New Fortress” or the “Company”) (NASDAQ: NFE) securities during the period of February 29, 2024 through August 8, 2024, inclusive (“the Class Period”). Investors have until November 18, 2024 to apply to the Court to be appointed as lead plaintiff in the lawsuit.

• Name Walgreens Boots Alliance, Inc.
• Type Securities
• Status Investigating
• The law firm of Kirby McInerney LLP announces that a class action lawsuit has been filed in the U.S. District Court for the Northern District of Illinois on behalf of those who acquired Walgreens Boots Alliance, Inc. et al. (“Walgreens” or the “Company”) (NASDAQ: WBA) securities during the period of July 1, 2021 through June 26, 2024, inclusive (“the Class Period”). Investors have until November 18, 2024 to apply to the Court to be appointed as lead plaintiff in the lawsuit.

• Name Allarity Therapeutics, Inc.
• Type Securities
• Status Investigating
• The law firm of Kirby McInerney LLP announces that a class action lawsuit has been filed in the U.S. District Court for the Southern District of New York on behalf of those who acquired Allarity Therapeutics, Inc. ("Allarity" or the "Company") (NASDAQ: ALLR) securities during the period of May 17, 2022 to July 19, 2024 inclusive (the "Class Period"). Investors have until November 12, 2024 to apply to the Court to be appointed as lead plaintiff in the lawsuit.

• Name Aviat Networks, Inc.
• Type Securities
• Status Investigating
• The law firm of Kirby McInerney LLP is investigating potential claims against Aviat Networks, Inc. (“Aviat” or the “Company”) (NASDAQ: AVNW). The investigation concerns whether Aviat and/or certain of its officers have violated the federal securities laws and/or engaged in other unlawful business practices.
   

• Name Coinbase Global, Inc.
• Type Securities
• Status Investigating
• The law firm of Kirby McInerney LLP announces that a class action lawsuit has been filed in the U.S. District Court for the Eastern District of Pennsylvania on behalf of those who acquired Coinbase Global, Inc. (“Coinbase” or the “Company”) (NASDAQ: COIN) securities during the period of April 14, 2021 to July 25, 2024, inclusive (“the Class Period”). Investors have until November 12, 2024 to apply to the Court to be appointed as lead plaintiff in the lawsuit.
   

• Name Dyne Therapeutics, Inc.
• Type Securities
• Status Investigating
• The law firm of Kirby McInerney LLP is investigating potential claims against Dyne Therapeutics, Inc. (“Dyne” or the “Company”) (NASDAQ: DYN). The investigation concerns whether Dyne and/or certain of its officers have violated the federal securities laws and/or engaged in other unlawful business practices.
   

• Name Napco Security Technologies, Inc.
• Type Securities
• Status Investigating
• The law firm of Kirby McInerney LLP is investigating potential claims against Napco Security Technologies, Inc. (“Napco” or the “Company”) (NASDAQ: NSSC). The investigation concerns whether Napco and/or certain of its officers have violated the federal securities laws and/or engaged in other unlawful business practices.
   

• Name Elastic N.V.
• Type Securities
• Status Investigating
• The law firm of Kirby McInerney LLP is investigating potential claims against Elastic N.V. (“Elastic” or the “Company”) (NASDAQ: ESTC). The investigation concerns whether Elastic and/or certain of its officers have violated the federal securities laws and/or engaged in other unlawful business practices.

• Name Liquidia Corporation
• Type Securities
• Status Investigating
• The law firm of Kirby McInerney LLP is investigating potential claims against Liquidia Corporation (“Liquidia” or the “Company”) (NASDAQ: LQDA). The investigation concerns whether Liquidia and/or certain of its officers have violated the federal securities laws and/or engaged in other unlawful business practices.
   

• Name Mynaric AG
• Type Securities
• Status Investigating
• The law firm of Kirby McInerney LLP is investigating potential claims against Mynaric AG (“Mynaric” or the “Company”) (NASDAQ: MYNA). The investigation concerns whether Mynaric and/or certain of its officers have violated the federal securities laws and/or engaged in other unlawful business practices.
   

• Name Franklin Resources, Inc.
• Type Securities
• Status Investigating
• The law firm of Kirby McInerney LLP is investigating potential claims against Franklin Resources, Inc. (“Franklin” or the “Company”) (NASDAQ: BEN). The investigation concerns whether Franklin and/or certain of its officers have violated the federal securities laws and/or engaged in other unlawful business practices.
   

• Name Globus Medical, Inc.
• Type Securities
• Status Investigating
• The law firm of Kirby McInerney LLP is investigating potential claims against Globus Medical, Inc. (“Globus Medical” or the “Company”) (NYSE: GMED). The investigation concerns whether Globus Medical and/or certain of its officers have violated the federal securities laws and/or engaged in other unlawful business practices.
   

• Name Cardlytics, Inc.
• Type Securities
• Status Investigating
• The law firm of Kirby McInerney LLP is investigating potential claims against Cardlytics, Inc. (“Cardlytics” or the “Company”) (NASDAQ: CDLX). The investigation concerns whether Cardlytics and/or certain of its officers have violated the federal securities laws and/or engaged in other unlawful business practices.
   

• Name Centuri Holdings, Inc.
• Type Securities
• Status Investigating
• The law firm of Kirby McInerney LLP is investigating potential claims against Centuri Holdings, Inc. (“Centuri” or the “Company”) (NYSE: CTRI). The investigation concerns whether Centuri and/or certain of its officers have violated the federal securities laws and/or engaged in other unlawful business practices.
   

• Name Medpace Holdings, Inc
• Type Securities
• Status Investigating
• The law firm of Kirby McInerney LLP is investigating potential claims against Medpace Holdings, Inc. (“Medpace” or the “Company”) (NASDAQ: MEDP). The investigation concerns whether Medpace and/or certain of its officers have violated the federal securities laws and/or engaged in other unlawful business practices.
   

• Name DexCom, Inc.
• Type Securities
• Status Investigating
• The law firm of Kirby McInerney LLP is investigating potential claims against DexCom, Inc. (“DexCom” or the “Company”) (NASDAQ: DXCM). The investigation concerns whether DexCom, and/or certain of its officers have violated the federal securities laws and/or engaged in other unlawful business practices.
   

• Name MaxLinear, Inc.
• Type Securities
• Status Investigating
• The law firm of Kirby McInerney LLP is investigating potential claims against MaxLinear, Inc. (“MaxLinear” or the “Company”) (NASDAQ: MXL). The investigation concerns whether MaxLinear and/or certain of its officers have violated the federal securities laws and/or engaged in other unlawful business practices.
  
   
   

• Name LPL Financial Holdings Inc.
• Type Securities
• Status Investigating
• The law firm of Kirby McInerney LLP is investigating potential claims against LPL Financial Holdings Inc. (“LPL Financial” or the “Company”) (NASDAQ: LPLA). The investigation concerns whether LPL Financial and/or certain of its officers have violated the federal securities laws and/or engaged in other unlawful business practices.
   

• Name CFTC v. Shak,
  No. 14-cv-01632 (D.D.C.).  
• Type Commodities
• Status Pending
• Representation of a defendant in a case brought by the CFTC under the Commodity Exchange Act’s newest provisions for violations of an administrative order in the gold futures market.

• Name In re Cattle Antitrust Litigation,
  No. 19-cv-1222 (D. Minn.).
• Type Commodities
• Status Pending
• Court-appointed executive committee member and class counsel representing cattle producers and cattle futures traders in a lawsuit alleging that the “Big 4” meatpacking firms conspired to suppress prices for fed cattle and manipulated live cattle futures traded on the Chicago Mercantile Exchange.

• Name Dufoe v. DraftKings Inc., et al, 23-cv-10524 (D.Mass.). 
• Type Securities
• Status Pending
• Lead counsel to a class of investors that purchased non-fungible tokens (NFTs) from DraftKings Inc., which operates as a daily fantasy sports contest and sports betting company. The case alleges that DraftKings sold unregistered securities and ensured that money stayed on DraftKings’ private and exclusively controlled marketplace, propping up the market for an overall valuation of DraftKings’ NFTs and significantly harming investors.  

• Name Macovski v. Groupon Inc.,
  No. 20-cv-2581 (N.D. Ill.).
• Type Securities
• Status Settled
• We acted as co-lead counsel in this securities class action alleging that the company made materially false and misleading statements and failed to disclose to investors its financial health before ending its sale of physical goods and announcing the departure of two top executives. The case resulted in a $13.5 million settlement that has received final approval.

• Name In re JPMorgan Treasury Futures Spoofing Litigation, 
  No. 20-cv-03515 (S.D.N.Y.).
• Type Antitrust, Commodities
• Status Settled
• Lead counsel in an antitrust case alleging that J.P. Morgan unlawfully and intentionally manipulated U.S. Treasury Futures or Options on U.S. Treasury Futures traded on United States-based exchanges, including but not limited to the Chicago Mercantile Exchange, including its subsidiary the Chicago Board of Trade, during the Class Period in violation of the Commodity Exchange Act, 7 U.S.C. §§ 1, et seq. (the “CEA”) and the common law.  The case resulted in a settlement of $15.7 million.

• Name Doyle v. Reata Pharmaceuticals, Inc.,
  No. 21-cv-00987 (E.D. Tex.).
• Type Securities
• Status Settled
• We are representing Wespath, the General Board of Pension and Health Benefits of the United Methodist Church, in this securities class action alleging that Reata Pharmaceuticals made false and/or misleading statements — including in connection with its secondary public stock offerings — concerning, inter alia, the FDA guidance regarding the design of the clinical trial (CARDINAL) for Reata’s drug candidate, bardoxolone methyl. When the FDA revealed serious concerns it had previously raised to Reata, the share price declined materially.  The case has resulted in a settlement of $45 million.

• Name CFTC Whistleblower Award,
  No. 21-WB-07
• Type Antitrust, CFTC Whistleblower, Commodities, False Claims Act, Whistleblower
• Status Settled
• KM represented the whistleblower who received nearly $200 million, the largest CFTC whistleblower award ever and the second largest whistleblower award arising under the Dodd-Frank and IRS whistleblower programs. The information the whistleblower provided catalyzed investigations by the Commodity Futures Trading Commission (CFTC), a U.S. federal regulator, and a foreign regulator into the manipulation of crucial financial benchmarks used by global banks as the basis for the pricing of fixed income securities and derivative products.  The CFTC initially rejected the whistleblower’s award application, but KM's advocacy resulted in a successful appeal for the client.

• Name Kokareva v. Bristow Group Inc., 
  No. 19-cv-00509 (S.D. Tex.).
• Type Securities
• Status Settled
• We acted as co-lead counsel in this securities class action alleging that an aviation services provider, focused on the oil and gas sector, made materially false and misleading statements about its internal controls relating to covenants in the company’s secured financing agreements. The case resulted in a $6.25 million settlement that has received final approval.

• Name In re Foreign Exchange Benchmark Rates Antitrust Litigation, 
  No. 13-cv-07789 (S.D.N.Y.).
• Type Antitrust, Commodities
• Status Settled
• Special fiduciary representation for the exchange-based class for a putative class of participants who traded futures and options in the FX market. The case has already resulted in partial settlements of more than $2.3 billion.

• Name In re Resonant Inc. Securities Litigation,
  No. 15-cv-01970 (C.D. Cal.).
• Type Securities
• Status Settled
• In re Resonant Inc. Securities Litigation, No. 15-cv-01970 (C.D. Cal. 2017).  Co-lead counsel.  $2.75 million settlement.

• Name Rothstein v. GMAC Mortgage LLC,
  No. 12-cv-03412 (S.D.N.Y.).
• Type Consumer Fraud
• Status Settled
• Rothstein v. GMAC Mortgage LLC, No. 12-cv-03412 (S.D.N.Y.).  Lead counsel.  $13 million settlement against GMAC Mortgage LLC in In re Residential Capital, LLC, No. 12-12020 (Bankr. S.D.N.Y. 2016).

• Name In re Hi-Crush Partners L.P. Securities Litigation,
  No. 12-cv-08557 (S.D.N.Y.).  
• Type Securities
• Status Settled
• In re Hi-Crush Partners L.P. Securities Litigation, No. 12-cv-08557 (S.D.N.Y. 2015).  Lead counsel.  $3.8 million settlement while class certification was pending.

• Name In re LIBOR-Based Financial Instruments Antitrust Litigation,
  No. 11-md-02262 (S.D.N.Y.). 
• Type Antitrust, Commodities
• Status Settled
• KM filed the first LIBOR manipulation lawsuit on behalf of investors and currently serves as court-appointed co-lead counsel for the exchange-based class alleging the fixing of prices of a benchmark interest rate. The case resulted in settlements totaling $190.45 million, which combined represent the largest recovery in a “futures-only” commodities class action litigation.

• Name In re Citigroup Inc Securities Litigation, 
  No. 07-cv-09901 (S.D.N.Y.).  
• Type Securities, Structured Finance
• Status Settled
• Lead counsel for individual investor lead plaintiffs in this securities fraud class action relating to Citigroup’s exposure to losses associated with its creation or sponsorship of numerous collateralized debt obligations (“CDOs”).  This case resulted in a settlement of $590 million for the class.  The settlement was, at the time, the largest CDO-related settlement ever, as well as the largest settlement of a fraud-only action.  A later filed SEC complaint concerning similar allegations settled for a small fraction of the class action settlement amount.